Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tubulin folding cofactor A pseudogene 2 (TBCAP2) is annotated as a *pseudogene*, not a protein-coding gene, and does not encode a functional protein. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they typically arise from gene duplication or retrotransposition events and lack protein-coding potential, regulatory elements, or both. There is no evidence to suggest TBCAP2 produces an active protein product or functions as a therapeutic target, enzyme, receptor, or cellular effector. Information regarding biological function, disease association, interacting drugs, or biomarker potential is lacking, as expected for pseudogenes. Any apparent association with cellular or disease processes is almost certainly coincidental or due to confusion with the protein-coding gene **TBCA (Tubulin folding cofactor A)**, which is involved in tubulin folding and microtubule assembly, but not its pseudogene forms[3].\n\nContextual clarification: \n- TBCA (Tubulin folding cofactor A), not TBCAP2, is a well-characterized protein-coding gene that acts as a chaperone in the folding of \u00df-tubulin during microtubule assembly, with known links to certain genetic disorders but is not a common direct therapeutic target[3][5].\n- TBCAP2, as a pseudogene, is not individually listed as a protein-coding target and has no established alias, functional classification, or drug interactions in authoritative databases.\n\nTherefore, **TBCAP2** is *not* a receptor, enzyme, transporter, or otherwise functional target, and information about biological or therapeutic relevance does not apply.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tubulin folding cofactor A pseudogene 2 (TBCAP2).